News: Sectors

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors
11:00aFMC FRESENIUS MEDICAL CARE AG & CO KGAA : Buy rating from DZ Bank
MD
10:32aMERCK KGAA : DZ Bank reaffirms its Buy rating
MD
10:00aTRANSCRIPT : CV Sciences, Inc., Q1 2022 Earnings Call, May 16, 2022
CI
10:00aTRANSCRIPT : Auxly Cannabis Group Inc., Q1 2022 Earnings Call, May 16, 2022
CI
10:00aTRANSCRIPT : Greenbrook TMS Inc., Q1 2022 Earnings Call, May 16, 2022
CI
09:44aEVOTEC : Receives a Buy rating from Berenberg
MD
09:00aTRANSCRIPT : Roche Holding AG - Special Call
CI
09:00aTRANSCRIPT : EL.En. S.p.A., Q1 2022 Earnings Call, May 16, 2022
CI
09:00aTRANSCRIPT : Nuvo Pharmaceuticals Inc., Q1 2022 Earnings Call, May 16, 2022
CI
08:30aTRANSCRIPT : Mind Medicine Inc., Q1 2022 Earnings Call, May 16, 2022
CI
08:30aTRANSCRIPT : Alaunos Therapeutics, Inc., Q1 2022 Earnings Call, May 16, 2022
CI
08:30aTRANSCRIPT : Synthetic Biologics, Inc., Q1 2022 Earnings Call, May 16, 2022
CI
08:30aTRANSCRIPT : Syros Pharmaceuticals, Inc., Q1 2022 Earnings Call, May 16, 2022
CI
08:30aTRANSCRIPT : Passage Bio, Inc., Q1 2022 Earnings Call, May 16, 2022
CI
08:30aTRANSCRIPT : Chimerix, Inc., Q1 2022 Earnings Call, May 16, 2022
CI
Discover
08:30aTRANSCRIPT : Novan, Inc., Q1 2022 Earnings Call, May 16, 2022
CI
08:30aTRANSCRIPT : MediPharm Labs Corp., Q1 2022 Earnings Call, May 16, 2022
CI
08:30aTRANSCRIPT : PolarityTE, Inc., Q1 2022 Earnings Call, May 16, 2022
CI
08:30aTRANSCRIPT : Protalix BioTherapeutics, Inc., Q1 2022 Earnings Call, May 16, 2022
CI
08:20aVALNEVA : Goldman Sachs reiterates its Buy rating
MD
08:00aTRANSCRIPT : Warby Parker Inc., Q1 2022 Earnings Call, May 16, 2022
CI
08:00aTRANSCRIPT : Gracell Biotechnologies Inc., Q1 2022 Earnings Call, May 16, 2022
CI
07:45aSTRATEC BIOMEDICAL SYSTEMS AG : Berenberg reaffirms its Neutral rating
MD
07:37aQIAGEN NV : Berenberg keeps its Buy rating
MD
07:37aCARL ZEISS MEDITEC AG : Gets a Buy rating from Deutsche Bank
MD
07:27aMERCK KGAA : Credit Suisse reiterates its Buy rating
MD
06:43aEU says no final decision taken on ending Valneva COVID vaccine contract
RE
05:40aCARL ZEISS MEDITEC AG : Buy rating from UBS
MD
05:39aBristol Myers Squibb Trial of Carcinoma Treatments Fails to Meet Primary Endpoint
DJ
04:54aMERCK KGAA : Receives a Buy rating from JP Morgan
MD
03:56aNetScientific Shares Rise on Successful Completion of AstraZeneca Covid-19 Antibody Test
DJ
03:26aTali Digital Limited Announces Changes in Registered Office
CI
03:19aTerumo Announces Change in Indication for Dexcom G6 CGM System in Japan
CI
03:17aSARTORIUS VORZUEGE : UBS takes a positive view
MD
03:00aNutex Health Announces Two New Fully Functional Micro Hospitals
CI
02:30aPharnext Announces New Results from the Ongoing Open-Label Follow-Up Extension Study of PXT3003
CI
02:00aImmunicum AB Announces Positive Interim Results from ADVANCE II Study in AML Maintenance Treatment
CI
02:00aFaron Announces US Food and Drug Administration and Finnish Medicines Agency Approval to Initiate Phase I/II Bexmarilimab Combination Study in Hematologic Malignancies
CI
02:00aShionogi & Co., Ltd. and F2G Ltd., Enter Strategic Collaboration to Develop and Commercialize the New Antifungal Agent Olorofim in Europe and Asia
CI
02:00aInventiva S.A. Secures A €50 Million Credit Facility from the European Investment Bank
CI
01:30aQIAGEN Expands Syndromic Testing Portfolio with the Launch of Higher-Capacity QIAstat-Dx Rise and Enhanced Panels
CI
01:30aNicox S.A. Announces Executive Changes
CI
05/16Innovent to Present Clinical Data of IBI110 (anti-LAG-3 monoclonal antibody) and Other Multiple Trials at the 2022 American Society of Clinical Oncology Annual Meeting
CI
05/161,232,000 Equity Shares of Par Drugs and Chemicals Limited are subject to a Lock-Up Agreement Ending on 16-MAY-2022.
CI
05/15Sanofi Says Phase 3 Study of Sarclisa Showed Longer Progression-Free Survival
DJ
05/15Antengene Announces Commercial Availability of XPOVIO®, for the Treatment of Relapsed/Refractory Multiple Myeloma, Prescribed for the First Time Across Mainland China
CI
05/15Shionogi & Co. Announces Initiation of a Phase 2/3 Clinical Trial in Japanese Adolescents for the Covid-19 Recombinant Protein-Based Vaccine, S-268019
CI
05/15Elan Corporation Provides Dividend Guidance for the Year Ending December 31, 2022
CI
05/15Elan Corporation Provides Consolidated Earnings Guidance for the Year Ending Six Months Ending June 30, 2022 and Full Year Ending December 31, 2022
CI
05/15Fukuda Denshi Co., Ltd. Revises Consolidated Earnings Guidance for the Year Ended Mach 31, 2022
CI
05/154DMedical Limited Announces Clinical Trial Results Presented At Top US Lung Conference
CI
05/15Mouwasat Medical Services Company Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/15Middle East Healthcare Company Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/15Urovant Sciences Ltd. Presents New Data from EMPOWUR Study, Advancing Knowledge of the Treatment of Overactive Bladder at the 2022 American Urological Association Meeting
CI
05/14Wattanapat Hospital Trang Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/14Calliditas Therapeutics AB Launches an Online Patient Platform
CI
05/14Anuh Pharma Limited Recommends Final Dividend for the Financial Year Ended 31 March 2022
CI
05/13OBI Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/13Mycenax Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/13MedFirst Healthcare Services, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/13Lotus Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/13Garofalo Health Care S.p.A. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/13INTAI Technology Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/13Health & Life Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/13Resverlogix Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Discover
05/13GlycoNex Incorporation Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/13Genovate Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/13FDA Approves Lilly's Mounjaro (Tirzepatide) Injection, the First and Only GIP and GLP-1 Receptor Agonist for the Treatment of Adults with Type 2 Diabetes
CI
05/13Foresee Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/13EirGenix Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
1  2  3  4  5  6  7  8  9  10Next